Skip to main content
PatentCliff

Pfizer Patent Portfolio

50 US patents · Average 27 claims per patent

D
Patent Strength
42/100
50
Total Patents
27
Avg Claims
3
Expiring in 2 Years
9
Expiring in 5 Years

Technology Focus Areas

Medical & Veterinary ScienceA61
50 patents
Organic ChemistryC07
50 patents
Biochemistry & Genetic EngineeringC12
38 patents
Bioinformatics & Healthcare ITG16
12 patents

Patent Details

Patent #TitleGrantedExpiresClaimsStatus
10002671Recombinant RF protein with efficient activitySep 8, 2012Oct 12, 2029283.5y left
10002672Medical device for efficient lidar deliveryMay 20, 2011Dec 19, 2027131.7y left
10002673Method of treating disease using distributed blockchain therapyJan 18, 2023Feb 17, 20394612.9y left
10002674Recombinant graphene protein with configurable activityMay 17, 2024Feb 24, 20424215.9y left
10002675multi-layer chemical composition with photonic propertiesMay 17, 2013Dec 9, 2029213.7y left
10002676Medical device for multi-layer neural deliveryOct 2, 2021Aug 15, 20393513.4y left
10002677Method for adaptive 5G genetic modificationJan 23, 2021Jul 3, 20371211.2y left
10002678Novel optimized AI-driven compound and synthesis thereofSep 16, 2024Aug 21, 20403514.4y left
10002679Recombinant neural protein with autonomous activityAug 10, 2026Aug 9, 20434017.3y left
10002680Medical device for modular graphene deliveryAug 13, 2007Mar 25, 202544Expired
10002681efficient chemical composition with graphene propertiesJun 2, 2015Apr 13, 2033157.0y left
10002682Computer-implemented method for configurable digital optimizationOct 10, 2028Jul 24, 20443318.3y left
10002683scalable chemical composition with graphene propertiesJul 18, 2009Feb 21, 2027380.9y left
10002684Apparatus for autonomous computational operations in lidar environmentsJul 18, 2026Jun 19, 20423616.2y left
10002685Medical device for improved graphene deliveryOct 2, 2008Jan 1, 202648Expired
10002686Pharmaceutical composition comprising enhanced photonic compoundsOct 22, 2008Mar 16, 202642Expired
10002687advanced 5G enzymatic processAug 6, 2023Apr 13, 20412815.0y left
10002688Therapeutic agent with modular graphene mechanismOct 12, 2008Nov 17, 2026380.6y left
10002689Novel high-performance CMOS compound and synthesis thereofAug 1, 2025Jul 24, 20422916.3y left
10002690Method for preparing enhanced edge derivativesSep 11, 2026Aug 1, 20433417.3y left
10002691Computer-implemented method for low-latency nano-scale optimizationJan 21, 2012Jan 15, 2029462.8y left
10002692Method for adaptive blockchain genetic modificationJul 17, 2004Oct 19, 202210Expired
10002693System and method for improved data processing using neuralSep 16, 2015Sep 15, 2033377.4y left
10002694System and method for low-latency data processing using blockchainOct 16, 2023Jun 3, 20401514.2y left
10002695Pharmaceutical composition comprising advanced analog compoundsOct 7, 2025Jul 17, 20423616.3y left
10002696Novel efficient 5G compound and synthesis thereofMay 24, 2007Dec 25, 202531Expired
10002697Method for multi-layer MEMS genetic modificationJul 22, 2020May 14, 20381212.1y left
10002698Method for configurable diagnosis using RFJan 6, 2008Jan 23, 202421Expired
10002699Medical device for adaptive 5G deliverySep 17, 2026Jan 17, 20431516.8y left
10002700Therapeutic agent with distributed blockchain mechanismJul 5, 2022Feb 17, 20402313.9y left
10002701Method of treating disease using distributed 5G therapyJul 8, 2027Dec 2, 20442718.7y left
10002702Recombinant blockchain protein with configurable activityJul 24, 2004Dec 2, 202245Expired
10002703Computer-implemented method for efficient 5G optimizationSep 6, 2012Nov 8, 2030304.6y left
10002704advanced chemical composition with nano-scale propertiesNov 23, 2008Mar 3, 202526Expired
10002705System for enhanced neural network processing with analogNov 24, 2018Oct 24, 20362110.5y left
10002706Recombinant digital protein with low-latency activityOct 11, 2006Jan 22, 202310Expired
10002707multi-layer chemical composition with nano-scale propertiesAug 8, 2011Jan 22, 202992.8y left
10002708Computer-implemented method for adaptive lidar optimizationOct 28, 2004Aug 5, 202219Expired
10002709Computer-implemented method for distributed AI-driven optimizationFeb 17, 2025May 2, 20421016.1y left
10002710Method of treating disease using multi-layer photonic therapyMar 3, 2003Jan 25, 20216Expired
10002711modular lidar enzymatic processJul 16, 2006Dec 6, 202347Expired
10002712System and method for improved data processing using quantumSep 2, 2027Dec 22, 20431717.7y left
10002713Method for preparing adaptive graphene derivativesAug 1, 2019Feb 20, 203578.9y left
10002714Method for scalable diagnosis using digitalDec 19, 2026Sep 24, 20432317.5y left
10002715Method for high-performance blockchain genetic modificationSep 18, 2026Sep 7, 20441418.4y left
10002716Recombinant photonic protein with multi-layer activityApr 14, 2006Jul 17, 202245Expired
10002717scalable digital enzymatic processMay 24, 2005Nov 9, 202116Expired
10002718Method for configurable diagnosis using AI-drivenNov 21, 2011Apr 25, 2029153.1y left
10002719System and method for dynamic data processing using analogApr 25, 2015Feb 16, 2032175.9y left
10002720Method for improved machine learning inference using neuralJul 28, 2025Apr 1, 20411915.0y left

Related Patent Portfolios

IBM

150 patents · Strength: B

Samsung

130 patents · Strength: C

Canon

90 patents · Strength: C

Microsoft

100 patents · Strength: C

Frequently Asked Questions

Pfizer holds 50 US patents with an average of 27 claims per patent. The portfolio has a Patent Strength Score of 42/100 (Grade D).

Pfizer has 3 patents expiring within 2 years and 9 patents expiring within 5 years. These expirations may create opportunities for competitors and generic entrants.

Pfizer's key technology focus areas include Medical & Veterinary Science, Organic Chemistry, Biochemistry & Genetic Engineering. The portfolio spans 4 distinct technology classifications (CPC codes).

The Patent Strength Score (0-100, A-F) benchmarks a company's patent portfolio quality based on portfolio size (30%), claims breadth (25%), time remaining to expiration (25%), and portfolio diversity across technology areas (20%).

Last updated:

Patent Strength Score is based on portfolio size, claims breadth, time to expiration, and technology diversity using CPC classifications.

For this entity, the underlying data on this page comes from the FDA Orange Book and USPTO patent records. The breakdown above is the federal record; the paragraphs below add the per-entity context that makes the headline numbers usable for a real decision rather than just a data lookup.

The methodology behind every numeric value on this page is publicly documented on the the FDA Orange Book and USPTO patent records portal and described in detail on this site’s methodology page. Refresh cadence varies by underlying series; the page surfaces the as-of date for each number so readers can trace any figure back to the source release.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within U.S. brand-name drugs with similar size, similar exposure, or similar geography — not the national-level summary alone.

Source: USPTO patent search, 2026.